Select Medical Holdings (SEM)
Pretax margin
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Earnings before tax but after interest (EBT) | US$ in thousands | 174,769 | 382,356 | 260,579 | 629,722 | 456,473 |
Revenue | US$ in thousands | 5,187,100 | 6,664,060 | 6,333,540 | 6,204,520 | 5,531,710 |
Pretax margin | 3.37% | 5.74% | 4.11% | 10.15% | 8.25% |
December 31, 2024 calculation
Pretax margin = EBT ÷ Revenue
= $174,769K ÷ $5,187,100K
= 3.37%
Select Medical Holdings' pretax margin has exhibited some fluctuation over the past five years. In December 2020, the pretax margin stood at 8.25%, showing a positive trend as it increased to 10.15% by December 2021. However, there was a significant decrease in the pretax margin to 4.11% in December 2022, indicating potential challenges or inefficiencies in the company's operations.
In the following years, there was a slight improvement in performance as the pretax margin rose to 5.74% by December 2023. Nonetheless, by December 2024, there was a notable decline in the pretax margin to 3.37%, suggesting that Select Medical Holdings may be facing financial pressures or cost management issues.
Overall, Select Medical Holdings' pretax margin analysis highlights the importance of monitoring and addressing factors affecting profitability to ensure sustainable financial performance in the long term.
Peer comparison
Dec 31, 2024